|
|
St. Jude Medical Riata Lead - News Articles
-
-
JUDE MEDICAL INC. (STJ) John C Heinmiller sold 107900 shares on 04/27/2011 at an average price of $53.37. St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. St. Jude Medical Inc. has a market cap of $17.4 billion; its shares were ...
-
-
St. Joseph Health System leadership will work with the hospital's board of trustees to appoint a new CEO, system officials said. Sisto, 60, has been with the system 24 years, starting as executive director of general services at St. Jude Medical Center in Fullerton. He was vice president of operations at St. Joseph Hospital in Orange before taking the helm in ...
-
-
St. Jude, Medtronic offer slightly different views on JAMA article impact. Two chief executives at two of the biggest medical device companies globally offered different opinions in recent months about the impact of an article about ICDs (implanted cardioverter defibrillators), and a Department of Justice investigation into these products. Neoprobe files SEC document to sell up to ...
-
-
Sisto, 60, took over at Queen of the Valley in 1998 after first working with St. Joseph Health System as executive director of general services at St. Jude Medical Center in Fullerton and then as vice president of operations at St. Joseph Hospital in Orange. “It is with mixed emotions that I announce my retirement,†Sisto said. “My career with St. Joseph’s — ...
-
-
A number of equity research firms have modified their stock ratings and price targets on shares of St. Jude Medical, Inc. (NYSE: STJ) in the last week: Deutsche Bank analysts reiterated a “buy” rating on shares of St. Jude Medical, Inc.. They now have a $55.00 price target on the stock. About St. Jude Medical, Inc.: St. Jude Medical, Inc. ...
-
-
St. Jude Medical Inc. said Tuesday a Los Angeles jury awarded it $2.3 billion in a lawsuit against a former employee of its heart device business and a Chinese company he founded. The company had said Yongning Zou stole trade secrets from the Pacesetter cardiac rhythm device unit, and tried to use those secrets to set up his own company, Nervicon Co. ...
-
-
St. Jude Medical (STJ), Abbott Laboratories (ABT): "I like JudeAbbott is better than that one (Medtronic) too." Monro Muffler Brake (MNRO), Cummins (CMI): "Monro Muffler is too cheap to be ignoredEven though Cummins has moved to $119, it hasn't made any money since the year began. It is just now catching up. I'd rather see you ...
-
-
Earlier this week, Little Canada-based St. Jude Medical CEO Daniel Starks was questioned about the impact of a Journal of American Medical Association article that described a study in which 22.5 percent of patients were implanted with ICDs when there was no evidence that they needed to be. Starks was also asked to comment on the effect of the ...
-
-
"Physicians around the world have already voiced tremendous excitement and satisfaction with the Trifecta valve," said Frank J. Callaghan, president of the St. Jude Medical Cardiovascular Division, in a statement. St. Jude's announcement comes the same day the company announced its first-quarter results . The company had revenue of $1.38 billion in the quarter ended ...
-
-
This is exactly what befell St. Jude Medical Colleges. A professor then was denounced by the school community after one of his students accused him allegedly of posting indecent photos of her in a social networking site. The damage caused by the incident reeled SJMC administrators, academic faculty, studentry, and alumni, said a statement e-mailed to ...
-
-
based St. Jude Medical (NYSE: STJ ) was questioned about the impact of an article in the Journal of the American Medical Association that described a study in which 22.5% of patients were implanted with ICDs when there was no evidence that they needed to be. Starks was also asked to comment on the effect of the government's investigation into ICDs. Starks, who ...
-
-
A number of equity research firms have modified their stock ratings and price targets on shares of St. Jude Medical, Inc. (NYSE: STJ) in the last week: Deutsche Bank analysts reiterated a “buy” rating on shares of St. Jude Medical, Inc.. Barclays Capital analysts raised their price target on shares of St. Jude Medical, Inc. from $50.00 to $56.00. They ...
-
-
Earlier this week, Little Canada, Minnesota-based St. Jude Medical CEO Daniel Starks was questioned about the impact of a Journal of American Medical Association article that described a study in which 22.5 percent of patients were implanted with ICDs when there was no evidence that they needed to be. Starks was also asked to comment on the effect ...
-
-
The JAMA study raised fears of a federal prosecution in cardiologists and both an investigation and sales slowdowns in large cardiac device makers like Boston Scientific Corp. (NYSE:BSX) and St. Jude Medical Inc. (NYSE:STJ). ...
-
-
Wall Street Journal
Medical devices giant St. Jude Medical (STJ - Analyst Report) continues its positive earnings surprise streak as its first-quarter 2011 adjusted earnings per share of 80 cents has topped the Zacks Consensus Estimates of 78 cents and exceeded the year-ago earnings of 75 cents. This represents the Minnesota-based company’s seventh consecutive quarter of outperformance. The adjusted earnings exclude ...
-
-
St. Jude Medical net off 2.2%; adjusted outlook up (7:52 AM ET) TEL AVIV (MarketWatch) - St. Jude Medical Inc., (NYSE:STJ) the St. Paul, Minn., producer of defibrillators and other medical devices, reported first-quarter net income slipped 2.2% on 9% higher sales and it raised its estimate of adjusted earnings for the year. Profit slipped to $233.4 million, or ...
-
-
St Jude Medical has been granted regulatory approval for a new technology offering that helps to improve the safety of defibrillation procedures. The company has received European CE mark and US Food and Drug Administration backing for the new ShockGuard technology, which is designed for use with its Unify cardiac resynchronisation therapy defibrillators and Fortify implantable cardioverter defibrillators. ...
-
-
Medgadget.com
Medical devices major St. Jude Medical (STJ - Analyst Report) has secured the clearance of the US Food and Drug Administration (“FDA”) and received the European CE approval for its ShockGuard technology, geared to reduce the occurrence of inappropriate and unnecessary shocks to patients with implantable cardioverter defibrillators (ICDs). The ShockGuard technology can be used with the Minnesota-based ...
-
-
Guests are invited to make a $10 donation to St. Jude when they book a party and the entire amount will go towards the lifesaving research and cutting edge medical treatment conducted at St. Jude. Build-A-Bear Workshop will match each guest's $10 ...
-
-
Regulators in the United States and Europe have approved a new technology developed by St. Jude Medical Inc. that is intended to protect defibrillator patients from receiving unnecessary shocks from the device. The announcement from the Little Canada-based medical technology company comes a few weeks after rival Medtronic Inc. launched a new defibrillator line that also ...
Pages:
1
2
3
4
5
6
...
Next
|
St. Jude Medical Riata Lead Information
|
